AU2001281407A1 - Amniotic apoptosis modulating substances - Google Patents
Amniotic apoptosis modulating substancesInfo
- Publication number
- AU2001281407A1 AU2001281407A1 AU2001281407A AU8140701A AU2001281407A1 AU 2001281407 A1 AU2001281407 A1 AU 2001281407A1 AU 2001281407 A AU2001281407 A AU 2001281407A AU 8140701 A AU8140701 A AU 8140701A AU 2001281407 A1 AU2001281407 A1 AU 2001281407A1
- Authority
- AU
- Australia
- Prior art keywords
- amniotic
- modulating substances
- apoptosis modulating
- apoptosis
- substances
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
- A61K8/981—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of mammals or bird
- A61K8/982—Reproductive organs; Embryos, Eggs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/48—Reproductive organs
- A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/86—Products or compounds obtained by genetic engineering
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Developmental Biology & Embryology (AREA)
- Pharmacology & Pharmacy (AREA)
- Reproductive Health (AREA)
- Zoology (AREA)
- Dermatology (AREA)
- Cell Biology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Birds (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Pregnancy & Childbirth (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US22411200P | 2000-08-09 | 2000-08-09 | |
US60224112 | 2000-08-09 | ||
PCT/US2001/041666 WO2002012444A2 (en) | 2000-08-09 | 2001-08-09 | Amniotic apoptosis modulating substances |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001281407A1 true AU2001281407A1 (en) | 2002-02-18 |
Family
ID=22839322
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001281407A Abandoned AU2001281407A1 (en) | 2000-08-09 | 2001-08-09 | Amniotic apoptosis modulating substances |
Country Status (4)
Country | Link |
---|---|
US (2) | US20020114846A1 (en) |
EP (1) | EP1309615A4 (en) |
AU (1) | AU2001281407A1 (en) |
WO (1) | WO2002012444A2 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1699809A4 (en) * | 2003-11-13 | 2009-10-21 | Lajor Biotech Inc | Amniotic-derived peptide and uses thereof |
CN111187750B (en) * | 2020-01-17 | 2022-08-16 | 复旦大学附属中山医院 | Method for inducing pluripotent stem cells to differentiate into myocardial cells by biogenic amine and application |
-
2001
- 2001-08-09 AU AU2001281407A patent/AU2001281407A1/en not_active Abandoned
- 2001-08-09 EP EP01959894A patent/EP1309615A4/en not_active Withdrawn
- 2001-08-09 WO PCT/US2001/041666 patent/WO2002012444A2/en not_active Application Discontinuation
- 2001-08-09 US US09/928,178 patent/US20020114846A1/en not_active Abandoned
-
2004
- 2004-03-08 US US10/795,819 patent/US20040170697A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP1309615A4 (en) | 2005-04-27 |
WO2002012444A2 (en) | 2002-02-14 |
WO2002012444A3 (en) | 2002-05-30 |
US20040170697A1 (en) | 2004-09-02 |
EP1309615A2 (en) | 2003-05-14 |
US20020114846A1 (en) | 2002-08-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001252612A1 (en) | Ppargamma modulators | |
AU6531400A (en) | Achromatic optical modulator | |
AU2001264879A1 (en) | Electrochromic devices | |
AU2002231325A1 (en) | Stat modulators | |
AU2001288623A1 (en) | Fxr modulators | |
AU2001286965A1 (en) | Sodium channel modulators | |
AU2000235960A1 (en) | Lxr modulators | |
AU2001243024A1 (en) | Cosmetic color determinate system | |
AU2002356843A1 (en) | Light modulation using the franz-keldysh effect | |
AU2001230605A1 (en) | Apoptosis inhibitor | |
AU3339500A (en) | Ferroelectric modulator | |
AU2001250541A1 (en) | Colour management | |
AU2001271426A1 (en) | Modulation of apoptosis | |
AU2002215110A1 (en) | Nonlinear systems | |
EP1368891B8 (en) | Iq modulator | |
AU5522300A (en) | Nanometer-scale modulation | |
AU6625700A (en) | Polarization independent grating modulator | |
AU2001279610A1 (en) | Bent electro-absorption modulator | |
AU2001281407A1 (en) | Amniotic apoptosis modulating substances | |
AU2001235454A1 (en) | Electrochromic dimmer system | |
AU2002328209A1 (en) | Hierarchical modulation | |
AU7353500A (en) | Apoptosis proteins | |
AU2001260647A1 (en) | Spatial light modulator | |
AU2001223878A1 (en) | Sealant | |
AU2000268585A1 (en) | Phase modulator |